Cancel
Roy Amariglio
Principal, OrbiMed, Board Observer
@
GentiBio
About Roy Amariglio
Roy Amariglio is a Principal at OrbiMed and serves as a Board Observer, holding both a PhD and an MBA.
Known information
Roy Amariglio holds prominent roles in the healthcare investment sector as a Principal at OrbiMed, where he leverages his extensive education and expertise. He also serves as a Board Observer, contributing his insights and oversight to various companies. Amariglio’s academic background is robust, with advanced degrees including a PhD and an MBA, equipping him with a deep understanding of both scientific and business aspects of the healthcare industry.
About GentiBio
GentiBio is a biotech company focused on developing engineered T regulatory cell therapies for various immune and inflammatory diseases, with its lead product GNTI-122 targeting type 1 diabetes.
Report inaccurate information
